West Virginia Legislature passes Michael Brandon Cochran Act for ICU patient testing

February 28, 2025 | Introduced Bills, House Bills, 2025 Bills, West Virginia Legislation Bills, West Virginia


This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »

West Virginia Legislature passes Michael Brandon Cochran Act for ICU patient testing
The West Virginia State Legislature has introduced House Bill 2789, known as the Michael Brandon Cochran Act, aimed at enhancing patient safety in intensive care units (ICUs) across the state. This legislation, introduced on February 28, 2025, mandates specific medical testing for patients presenting with severe hypoglycemia or unconsciousness, addressing critical gaps in current hospital protocols.

At the heart of the bill is the requirement for hospitals to administer a C-peptide test to ICU patients who exhibit blood glucose levels of 49 mg/dl or lower, regardless of any prior diabetes diagnosis. This test measures a protein produced alongside insulin, providing vital information about a patient's insulin production and potential underlying conditions. Additionally, if a patient dies under circumstances suggesting brain damage or severe hypoglycemia, a post-mortem C-peptide test is mandated.

The bill also establishes a monetary penalty of $10,000 for hospitals that fail to comply with these testing requirements, emphasizing the importance of adherence to patient safety standards. To support hospitals in implementing these changes, the legislation creates the Michael Brandon Cochran Grant Program, which will provide funding for the costs associated with administering the tests and training healthcare staff on recognizing hypoglycemia symptoms.

The introduction of this bill has sparked discussions among healthcare professionals and lawmakers about its potential impact on patient care. Proponents argue that the legislation could significantly reduce the risk of misdiagnosis and improve outcomes for critically ill patients. However, some hospital administrators have raised concerns about the financial implications of the penalties and the administrative burden of compliance.

As the bill progresses through the legislative process, its implications for West Virginia's healthcare system are becoming clearer. Experts suggest that if passed, the Michael Brandon Cochran Act could set a precedent for similar legislation in other states, potentially reshaping how hospitals approach patient safety in ICUs.

In conclusion, House Bill 2789 represents a significant step toward improving medical protocols in West Virginia's hospitals, with the potential to save lives and enhance the quality of care for some of the state's most vulnerable patients. As the legislature continues to debate the bill, the focus remains on ensuring that patient safety is prioritized in every ICU across West Virginia.

View Bill

This article is based on a bill currently being presented in the state government—explore the full text of the bill for a deeper understanding and compare it to the constitution

View Bill